Summary

This report is an essential source for data, analysis and strategic insight into the medical equipment business of Qiagen N.V.. The report provides key information relating to Qiagen N.V.  medical equipment revenue, market share by sector and country, financial and SWOT analysis of the company. The report examines the medical equipment business structure and operations, history and products, and provides an analysis of its key medical equipment revenue lines. It inspects the company's strategic strengths and weaknesses.

Scope

-Revenues for the medical equipment markets and sub-sectors by country and region.
-Provides the share of market and sub sectors by country and region.
-Detailed breakdown revenues contributed by the medical equipment business operations.
-Provides summary of the medical equipment pipeline products that the company is developing.
-Critical analysis of the company's strengths, weaknesses opportunities and threats.
-Provides summary analysis of key revenue lines and strategy.
-Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
-Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

-A single source to fulfill all of your business and competitor intelligence needs
-Research your competitor's business structure, strategy and prospects.
-Counter your competitor's strengths and target their weaknesses.
-Identify your competitor's key revenue streams by market and geography.
-Identify and assess potential corporate and investment opportunities.
-Support sales activities by understanding your customers businesses better.
-Identify potential competitor products before they reach market.
-Qualify prospective partners and suppliers.

Table of Contents

1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets/Categories Covered 10
3.1 In Vitro Diagnostics 10
3.1.1 Genetic Test Reagents 10
3.1.2 Immunochemistry Test Reagents 10
3.1.3 Infectious Immunology Test Reagents 10
3.1.4 Microbiology Test Reagents 10
4 Company Snapshot 11
4.1 Key Information 11
4.2 Company Overview 11
4.3 Financial Performance 11
4.4 SWOT Snapshot 11
4.5 Business Overview 12
4.6 Major Products and Services 13
4.6.1 Overview 13
5 History 15
6 SWOT Analysis 17
6.1 Overview 17
6.2 Qiagen N.V. Strengths 17
6.2.1 Strong Financial Performance 17
6.2.2 Broad Product Portfolio 18
6.2.3 Wide Geographical Presence 18
6.2.4 Strong Growth Prospects 18
6.2.5 Intellectual Property 18
6.2.6 Expanding Market Share in Sector 18
6.2.7 Expanding Operating Margin 18
6.3 Qiagen N.V. Weaknesses 19
6.3.1 Long Term Debts 19
6.3.2 Low Return on Equity 19
6.4 Qiagen N.V. Opportunities 19
6.4.1 New Product Launches 19
6.4.2 Research and Development Activities 19
6.4.3 Strategic Alliances 20
6.5 Qiagen N.V. Threats 20
6.5.1 Product Liability Claims 20
6.5.2 Intense Competition 20
6.5.3 Stringent Government Regulations 21
7 Competitors 22
8 Qiagen N.V. Medical Equipment Market Share Analysis 23
8.1 Qiagen N.V., In Vitro Diagnostics, Global, Market Share (2008) 23
8.2 Qiagen N.V., APAC, Market Share (2008) 24
8.3 Qiagen N.V., Europe, Market Share (2008) 25
8.4 Qiagen N.V., MEA, Market Share (2008) 26
8.5 Qiagen N.V., North America, Market Share (2008) 27
8.6 Qiagen N.V., SCA, Market Share (2008) 28
9 Qiagen N.V. Medical Equipment Market Share Analysis by Category 29
9.1 Qiagen N.V., In Vitro Diagnostics, Global, Category Revenue Share (2008) 29
9.2 Qiagen N.V., APAC, Category Revenue Share (2008) 31
9.3 Qiagen N.V., Europe, Category Revenue Share (2008) 43
9.4 Qiagen N.V., MEA, Category Revenue Share (2008) 57
9.5 Qiagen N.V., North America, Category Revenue Share (2008) 59
9.6 Qiagen N.V., SCA, Category Revenue Share (2008) 65
10 Key Employees 71
11 Key Employee Biographies 72
12 Locations And Subsidiaries 73
12.1 Head Office 73
12.2 Other Locations & Subsidiaries 73
13 Recent Developments 76
13.1 Strategy And Business Planning 76
13.1.1 Jan 12, 2009: QIAGEN led-Consortium Launches Project To Improve In-Vitro Diagnostics 76
13.2 Financial Announcements 77
13.2.1 May 04, 2009: Qiagen Posts Profit Of $24.6 Million In Q1 2009 77
13.2.2 Feb 09, 2009: Qiagen Reports Preliminary 2008 Results 78
13.2.3 Nov 10, 2008: Qiagen Reports 3Q 2008 Results 80
13.2.4 Aug 04, 2008: Qiagen Reports 2Q 2008 Results 81
13.3 Research And Development 82
13.3.1 Jan 12, 2009: QIAGEN led-Consortium Launches Project To Improve In-Vitro Diagnostics 82
13.4 Corporate Communications 83
13.4.1 Jan 26, 2009: QIAGEN Appoints New President For QIAGEN Japan 83
13.4.2 Jan 19, 2009: QIAGEN Appoints New Head, Global Regulatory Affairs 83
13.5 Legal and Regulatory 84
13.5.1 Apr 01, 2009: Qiagen Announces CAFC Rejects Third Wave 84
13.5.2 Jan 22, 2009: QIAGEN And Applied Biosystems Settle All Disputes Over Real-Time PCR Thermal Cycler Patents 85
13.6 Product News 85
13.6.1 Jun 03, 2009: QIAGEN's Next Generation Molecular Diagnostic Receives CE Mark Approval For KRAS Analysis 85
13.6.2 May 25, 2009: QIAGEN Announces Launch Of QIAamp Circulating Nucleic Acid Kit For Extraction Of Free Circulating DNA And RNA Fragments 86
13.6.3 Apr 28, 2009: QIAGEN Provides Screening Tests For Swine Flu Virus 87
13.6.4 Apr 01, 2009: Landmark Study Shows Significant Reduction In Death Rate From Cervical Cancer With The Digene HPV Test Compared To Other Methods Including Pap 88
13.6.5 Mar 06, 2009: QIAGEN Supports Cervical Cancer Screening For Underprivileged Chinese Women 88
13.6.6 Nov 10, 2008: QIAGEN Introduces CE-marked Molecular Assay For The Cancer Biomarker K-ras 89
13.6.7 Sep 22, 2008: First Published Study Of New HPV Test For Developing Countries Shows High Accuracy In Predicting Cervical Disease 90
13.6.8 Aug 19, 2008: QIAGEN Unveils Diagnostic Assay In The EU To Detect Genetic Variation Causing Adverse Reactions In AIDS Patients 90
13.7 Other Significant Developments 91
13.7.1 May 28, 2009: Qiagen Awards Development Contract To Plexus 91
13.7.2 May 28, 2009: Qiagen To Supply Molecular Screening Solutions To Increase Safety Of Blood Donations In Brazil 91
13.7.3 Sep 22, 2008: Osmetech Signs Agreement With Qiagen For QIAplex-Based Respiratory Viral Molecular Test 92
13.7.4 Sep 18, 2008: Qiagen CEO To Present At UBS Conference 93
13.7.5 Dec 19, 2007: QIAGEN, Ventana Announce Settlement Of Patent Dispute 93
14 Appendix 94
14.1 Research Methodology 95
14.2 Secondary Research 96
14.3 Primary Research 96
14.4 Models 97
14.5 Forecasts 97
14.6 Expert Panels 97
14.7  Consulting 98
14.8 Contact Us 98
14.9 Disclaimer 98

1.1 List of Tables
Table 1:Qiagen N.V., Key Facts, 2009 11
Table 2:Qiagen N.V., SWOT Analysis, 2008 17
Table 3:Qiagen N.V., In Vitro Diagnostics, Global, Revenue ($ mn) and Market Share (%), 2008 23
Table 4:Qiagen N.V., In Vitro Diagnostics, APAC, Revenue ($ mn) and Market Share (%), 2008 24
Table 5:Qiagen N.V., In Vitro Diagnostics, Europe, Revenue ($ mn) and Market Share (%), 2008 25
Table 6:Qiagen N.V., In Vitro Diagnostics, MEA, Revenue ($ mn) and Market Share (%), 2008 26
Table 7:Qiagen N.V., In Vitro Diagnostics, North America, Revenue ($ mn) and Market Share (%), 2008 27
Table 8:Qiagen N.V., In Vitro Diagnostics, SCA, Revenue ($ mn) and Market Share (%), 2008 28
Table 9:Qiagen N.V., In Vitro Diagnostics, Global, Revenue ($ mn) and Market Share (%) by Category, 2008 30
Table 10:Qiagen N.V., In Vitro Diagnostics, APAC, Revenue ($ mn) and Market Share (%) by Category, 2008 32
Table 11:Qiagen N.V., In Vitro Diagnostics, Australia, Revenue ($ mn) and Market Share (%) by Category, 2008 34
Table 12:Qiagen N.V., In Vitro Diagnostics, China, Revenue ($ mn) and Market Share (%) by Category, 2008 36
Table 13:Qiagen N.V., In Vitro Diagnostics, India, Revenue ($ mn) and Market Share (%) by Category, 2008 38
Table 14:Qiagen N.V., In Vitro Diagnostics, Japan, Revenue ($ mn) and Market Share (%) by Category, 2008 40
Table 15:Qiagen N.V., In Vitro Diagnostics, Others, Revenue ($ mn) and Market Share (%) by Category, 2008 42
Table 16:Qiagen N.V., In Vitro Diagnostics, Europe, Revenue ($ mn) and Market Share (%) by Category, 2008 44
Table 17:Qiagen N.V., In Vitro Diagnostics, France, Revenue ($ mn) and Market Share (%) by Category, 2008 46
Table 18:Qiagen N.V., In Vitro Diagnostics, Germany, Revenue ($ mn) and Market Share (%) by Category, 2008 48
Table 19:Qiagen N.V., In Vitro Diagnostics, Italy, Revenue ($ mn) and Market Share (%) by Category, 2008 50
Table 20:Qiagen N.V., In Vitro Diagnostics, Spain, Revenue ($ mn) and Market Share (%) by Category, 2008 52
Table 21:Qiagen N.V., In Vitro Diagnostics, United Kingdom, Revenue ($ mn) and Market Share (%) by Category, 2008 54
Table 22:Qiagen N.V., In Vitro Diagnostics, Others, Revenue ($ mn) and Market Share (%) by Category, 2008 56
Table 23:Qiagen N.V., In Vitro Diagnostics, MEA, Revenue ($ mn) and Market Share (%) by Category, 2008 58
Table 24:Qiagen N.V., In Vitro Diagnostics, North America, Revenue ($ mn) and Market Share (%) by Category, 2008 60
Table 25:Qiagen N.V., In Vitro Diagnostics, Canada, Revenue ($ mn) and Market Share (%) by Category, 2008 62
Table 26:Qiagen N.V., In Vitro Diagnostics, United States, Revenue ($ mn) and Market Share (%) by Category, 2008 64
Table 27:Qiagen N.V., In Vitro Diagnostics, SCA, Revenue ($ mn) and Market Share (%) by Category, 2008 66
Table 28:Qiagen N.V., In Vitro Diagnostics, Brazil, Revenue ($ mn) and Market Share (%) by Category, 2008 68
Table 29:Qiagen N.V., In Vitro Diagnostics, Others, Revenue ($ mn) and Market Share (%) by Category, 2008 70
Table 30:Qiagen N.V., Key Employees 71
Table 31:Qiagen N.V., Subsidiaries 73

1.2 List of Figures
Figure 1:Qiagen N.V., In Vitro Diagnostics, Global, Market Share (%), 2008 23
Figure 2:Qiagen N.V., In Vitro Diagnostics, APAC, Market Share (%), 2008 24
Figure 3:Qiagen N.V., In Vitro Diagnostics, Europe, Market Share (%), 2008 25
Figure 4:Qiagen N.V., In Vitro Diagnostics, MEA, Market Share (%), 2008 26
Figure 5:Qiagen N.V., In Vitro Diagnostics, North America, Market Share (%), 2008 27
Figure 6:Qiagen N.V., In Vitro Diagnostics, SCA, Market Share (%), 2008 28
Figure 7:Qiagen N.V., In Vitro Diagnostics, Global, Category Revenue Share (%), 2008 29
Figure 8:Qiagen N.V., In Vitro Diagnostics, Global, Market Share (%) by Category, 2008 30
Figure 9:Qiagen N.V., In Vitro Diagnostics, APAC, Category Revenue Share (%), 2008 31
Figure 10:Qiagen N.V., In Vitro Diagnostics, APAC, Market Share (%) by Category, 2008 32
Figure 11:Qiagen N.V., In Vitro Diagnostics, Australia, Category Revenue Share (%), 2008 33
Figure 12:Qiagen N.V., In Vitro Diagnostics, Australia, Market Share (%) by Category, 2008 34
Figure 13:Qiagen N.V., In Vitro Diagnostics, China, Category Revenue Share (%), 2008 35
Figure 14:Qiagen N.V., In Vitro Diagnostics, China, Market Share (%) by Category, 2008 36
Figure 15:Qiagen N.V., In Vitro Diagnostics, India, Category Revenue Share (%), 2008 37
Figure 16:Qiagen N.V., In Vitro Diagnostics, India, Market Share (%) by Category, 2008 38
Figure 17:Qiagen N.V., In Vitro Diagnostics, Japan, Category Revenue Share (%), 2008 39
Figure 18:Qiagen N.V., In Vitro Diagnostics, Japan, Market Share (%) by Category, 2008 40
Figure 19:Qiagen N.V., In Vitro Diagnostics, Others, Category Revenue Share (%), 2008 41
Figure 20:Qiagen N.V., In Vitro Diagnostics, Others, Market Share (%) by Category, 2008 42
Figure 21:Qiagen N.V., In Vitro Diagnostics, Europe, Category Revenue Share (%), 2008 43
Figure 22:Qiagen N.V., In Vitro Diagnostics, Europe, Market Share (%) by Category, 2008 44
Figure 23:Qiagen N.V., In Vitro Diagnostics, France, Category Revenue Share (%), 2008 45
Figure 24:Qiagen N.V., In Vitro Diagnostics, France, Market Share (%) by Category, 2008 46
Figure 25:Qiagen N.V., In Vitro Diagnostics, Germany, Category Revenue Share (%), 2008 47
Figure 26:Qiagen N.V., In Vitro Diagnostics, Germany, Market Share (%) by Category, 2008 48
Figure 27:Qiagen N.V., In Vitro Diagnostics, Italy, Category Revenue Share (%), 2008 49
Figure 28:Qiagen N.V., In Vitro Diagnostics, Italy, Market Share (%) by Category, 2008 50
Figure 29:Qiagen N.V., In Vitro Diagnostics, Spain, Category Revenue Share (%), 2008 51
Figure 30:Qiagen N.V., In Vitro Diagnostics, Spain, Market Share (%) by Category, 2008 52
Figure 31:Qiagen N.V., In Vitro Diagnostics, United Kingdom, Category Revenue Share (%), 2008 53
Figure 32:Qiagen N.V., In Vitro Diagnostics, United Kingdom, Market Share (%) by Category, 2008 54
Figure 33:Qiagen N.V., In Vitro Diagnostics, Others, Category Revenue Share (%), 2008 55
Figure 34:Qiagen N.V., In Vitro Diagnostics, Others, Market Share (%) by Category, 2008 56
Figure 35:Qiagen N.V., In Vitro Diagnostics, MEA, Category Revenue Share (%), 2008 57
Figure 36:Qiagen N.V., In Vitro Diagnostics, MEA, Market Share (%) by Category, 2008 58
Figure 37:Qiagen N.V., In Vitro Diagnostics, North America, Category Revenue Share (%), 2008 59
Figure 38:Qiagen N.V., In Vitro Diagnostics, North America, Market Share (%) by Category, 2008 60
Figure 39:Qiagen N.V., In Vitro Diagnostics, Canada, Category Revenue Share (%), 2008 61
Figure 40:Qiagen N.V., In Vitro Diagnostics, Canada, Market Share (%) by Category, 2008 62
Figure 41:Qiagen N.V., In Vitro Diagnostics, United States, Category Revenue Share (%), 2008 63
Figure 42:Qiagen N.V., In Vitro Diagnostics, United States, Market Share (%) by Category, 2008 64
Figure 43:Qiagen N.V., In Vitro Diagnostics, SCA, Category Revenue Share (%), 2008 65
Figure 44:Qiagen N.V., In Vitro Diagnostics, SCA, Market Share (%) by Category, 2008 66
Figure 45:Qiagen N.V., In Vitro Diagnostics, Brazil, Category Revenue Share (%), 2008 67
Figure 46:Qiagen N.V., In Vitro Diagnostics, Brazil, Market Share (%) by Category, 2008 68
Figure 47:Qiagen N.V., In Vitro Diagnostics, Others, Category Revenue Share (%), 2008 69
Figure 48:Qiagen N.V., In Vitro Diagnostics, Others, Market Share (%) by Category, 2008 70
Figure 49:  Methodology 95